Fidelity Investments’s Mineralys Therapeutics MLYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.13M | Buy |
304,886
+128
| +0% | +$1.73K | ﹤0.01% | 2237 |
|
|
2025
Q1 | $4.84M | Buy |
304,758
+574
| +0.2% | +$9.12K | ﹤0.01% | 2157 |
|
|
2024
Q4 | $3.74M | Buy |
304,184
+426
| +0.1% | +$5.24K | ﹤0.01% | 2256 |
|
|
2024
Q3 | $3.68M | Buy |
303,758
+32,663
| +12% | +$396K | ﹤0.01% | 2217 |
|
|
2024
Q2 | $3.17M | Buy |
271,095
+269,551
| +17,458% | +$3.15M | ﹤0.01% | 2212 |
|
|
2024
Q1 | $19.9K | Sell |
1,544
-29,743
| -95% | -$384K | ﹤0.01% | 4017 |
|
|
2023
Q4 | $269K | Sell |
31,287
-1,157,366
| -97% | -$9.95M | ﹤0.01% | 2861 |
|
|
2023
Q3 | $11.3M | Buy |
1,188,653
+457,815
| +63% | +$4.35M | ﹤0.01% | 1790 |
|
|
2023
Q2 | $12.5M | Buy |
730,838
+730,209
| +116,090% | +$12.5M | ﹤0.01% | 1791 |
|
|
2023
Q1 | $9.85K | Buy |
+629
| New | +$9.85K | ﹤0.01% | 4136 |
|